Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Blackstone heads into Thursday's third-quarter earnings with short sellers pulling back, analysts trimming targets, and options hedges sitting at their most defensive point in weeks.
The analyst picture has turned cautious in the final days before the print. TD Cowen cut its price target on Monday from $154 to $144, keeping a Buy rating. Barclays followed last week with a trim from $128 to $124, holding Equal-Weight. Wells Fargo initiated coverage at Equal-Weight with a $122 target. All three moves are pointed in the same direction: a Street that still broadly sees upside from the current $114.78 level but is becoming more selective on near-term execution. The consensus target of $141 implies roughly 23% above current levels, a gap that partly reflects the stock's 11% decline over the past month.
The bull and bear cases are tightly drawn around one number: fee-related earnings. Bulls argue that Blackstone's $1.35 trillion AUM base delivers powerful operating leverage, and that wealth-channel inflows, improving realization activity, and a trough in real estate create a natural earnings inflection into 2027. Bears counter that second-quarter management fees already missed consensus, credit and real estate fees fell sequentially, and BCRED redemptions have kept near-term revenue conversion soft. The resolution depends on whether the realization pipeline bulls have been citing actually starts moving in Q3, or whether the lag before recently raised capital becomes fee-paying extends the pressure.
Options traders have moved more defensively in the past two weeks. The put/call ratio has climbed to 1.72, above its 20-day average of 1.65 and close to the 52-week high of 1.87. The previous note from October 7 recorded the PCR easing, but since then it has pushed back up. The z-score of 0.90 is not extreme, but the direction is clear. Elsewhere, the lending market remains entirely untroubled: borrow costs are near 0.39% and availability is above 2,680%, meaning there are roughly 27 shares available in the lending pool for every one currently borrowed. Short interest edged up to 2.9% of the free float on October 9, recovering a prior peak, though at those levels the short base is not a structural headwind.
Insider activity leans negative on a 90-day net basis, with $24.4 million in net sales since late July. The largest cluster came on September 18, when director Joseph Baratta sold just over 100,000 shares worth roughly $12.4 million across two transactions, neither under a 10b5-1 plan. The Chief Legal Officer and Chief Accounting Officer also sold in August near the $145-to-147 range, well above where the stock trades now. None of these sales are unusual for a firm where senior executives hold large long-term positions, but the absence of any open-market buying into the decline is a data point worth noting.
Thursday's print is less a test of whether Blackstone is growing and more a question of whether the fee conversion story that bulls have been waiting on is visible in the Q3 figures.
See the live data behind this article on ORTEX.
Open BX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
